<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941125-2-00095</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> 3. Abbreviated New Drug Application Regulations; Patent and Exclusivity Provisions, Final Rule_New_These regulations provide instructions on how to file patent information, request market exclusivity, and describe the Food and Drug Administration's guidelines regarding patents and exclusivity. Respondents: Businesses or other for-profit, Small businesses or organizations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 4,L2,tp0,i1,s50,8,8,8 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Title <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1No. of respondents <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1No. of responses per respondent <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Average burden per response (hours) <!-- PJG 0012 frnewline -->  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Reporting: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=02 g=1 f=1 --> 314.50(i)  <!-- PJG 007 0104 intable --> 8  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 2 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.50(j)  <!-- PJG 007 0104 intable --> 50  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 2 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.52  <!-- PJG 007 0104 intable --> 30  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 8 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.53  <!-- PJG 007 0104 intable --> 200  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 1 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.54  <!-- PJG 007 0104 intable --> 10  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 1 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.70  <!-- PJG 007 0104 intable --> 43  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 1 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.94(a)(12)  <!-- PJG 007 0104 intable --> 215  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 2 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.95  <!-- PJG 007 0104 intable --> 30  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 16 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 314.107  <!-- PJG 007 0104 intable --> 10  <!-- PJG 007 0104 intable --> 1  <!-- PJG 007 0104 intable --> 1 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> Estimated total annual burden: 1,529 hours. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 4. Evaluation of the Community-Based Mosquito Control Programs for Dengue Hemorrhagic Fever (DHF) Prevention and Control at the San Juan Laboratories, Puerto Rico_New_The information generated from this evaluation project will be used to improve the DHF prevention program in Puerto Rico, and programs modeled after the Centers for Disease Control (CDC) program in other countries in the Americas. The lessons learned from this evaluation would be of great use for similar situations, regarding dengue in other countries, or situations involving the emergence of other new diseases, or diseases that are changing in epidemiologic pattern. Respondents: Individuals or households; Respondents: 1,500; Number of Responses per Respondent: 1; Average Burden per Response: .68 hour; Estimated Annual Burden: 1,022 hours. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5. OMAR Quick Launch Physician Practice Survey_0925&hyph;0367 (Extension, no change)_The Office of Medical Applications of Research (OMAR) will conduct surveys of physicians to evaluate changes in their practice behavior related to biomedical technologies that are assessed in Consensus Development Conferences (CDC). For each CDC, identical surveys will be conducted at three times: one year before, just before, and one-year following a CDC. Respondents: Individuals or households, Businesses or other for-profit, Small businesses or organizations. Total Annual Burden: 1 hour.* <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> *Note: <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  This is a  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> concept <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  approval, only. Under terms of the current approval, questionnaires for each CDC survey must be submitted to OMB for approval. OMB has agreed to give those submissions an expedited 30-day review. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 6. Evaluation of Tuberculosis Outreach Worker Activities_New_This survey is a necessary step prior to developing a plan to evaluate the outreach activities of State and local tuberculosis control programs. The purpose of this project is to describe the outreach activities and outreach workers. This will be accomplished by conducting a mail survey of State and local tuberculosis control programs. Respondents: State or local governments; Number of Respondents: 64; Number of Responses per Respondent: 1; Average Burden per Response: 2.65 hours; Estimated Annual Burden: 170 hours. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Written comments and recommendations concerning the proposed information collections should be sent within 30 days of this notice directly to the OMB Desk Officer designated below at the following address: Shannah Koss, Human Resources and Housing Branch, New Executive Office Building, room 10235, Washington, DC 20503. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: November 11, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> James Scanlon, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, Division of Data Policy, Office of Health Planning and Evaluation. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;29184 Filed 11&hyph;23&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;17&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            